W M Kast - JoVE Visualize

Showing results (101-110 of 128) with videos related to

Pageof 13

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995

MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cellsM J Kleijmeer, M A Ossevoort, C J van Veen, et al.

Cancer Research|October 28, 1999

Successful immunotherapy of an intraocular tumor in miceL R Schurmans, A T den Boer, L Diehl, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesM E Ressing, A Sette, R M Brandt, et al.

Cancer Research|June 15, 1995

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2E Hooijberg, J J Sein, P C van den Berk, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cellsR E Toes, E I van der Voort, S P Schoenberger, et al.

European Journal of Immunology|June 1, 1993

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.

European Journal of Immunology|May 6, 1999

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaM E Ressing, J H de Jong, R M Brandt, et al.

Journal of Virology|September 1, 1994

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 miceA J Sijts, M L De Bruijn, M E Ressing, et al.

Nature Medicine|December 1, 1995

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityJ I Mayordomo, T Zorina, W J Storkus, et al.

European Journal of Immunology|September 1, 1993

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsM C Feltkamp, H L Smits, M P Vierboom, et al.

Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:

Pageof 13

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995

MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cellsM J Kleijmeer, M A Ossevoort, C J van Veen, et al.

Cancer Research|October 28, 1999

Successful immunotherapy of an intraocular tumor in miceL R Schurmans, A T den Boer, L Diehl, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesM E Ressing, A Sette, R M Brandt, et al.

Cancer Research|June 15, 1995

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2E Hooijberg, J J Sein, P C van den Berk, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cellsR E Toes, E I van der Voort, S P Schoenberger, et al.

European Journal of Immunology|June 1, 1993

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.

European Journal of Immunology|May 6, 1999

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaM E Ressing, J H de Jong, R M Brandt, et al.

Journal of Virology|September 1, 1994

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 miceA J Sijts, M L De Bruijn, M E Ressing, et al.

Nature Medicine|December 1, 1995

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityJ I Mayordomo, T Zorina, W J Storkus, et al.

European Journal of Immunology|September 1, 1993

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsM C Feltkamp, H L Smits, M P Vierboom, et al.

Pageof 13